SCHEMBL20525565

SCHEMBL20525565

COc1c(OCC2CCNCC2)ccc2c(Oc3ccc(NC(=O)C(=O)NCc4cc(Cl)cc(Cl)c4)cc3F)ccnc12

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MET P08581 17/20 0.47
FLT3 P36888 2/20 0.41
AXL P30530 1/20 0.37
KDR P35968 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20525822 0.94 MET (0.47) METFLT3AXLKDR
SCHEMBL20525691 0.94 MET (0.47) METFLT3KDR
SCHEMBL20525722 0.93 MET (0.46) METFLT3AXLKDR
SCHEMBL20525693 0.93 MET (0.48) METFLT3AXLKDR
SCHEMBL20525751 0.92 MET (0.47) METFLT3AXLKDR
SCHEMBL20525701 0.92 MET (0.49) METFLT3AXLKDR
SCHEMBL20525667 0.92 MET (0.53) METFLT3AXLKDR
SCHEMBL20525653 0.92 MET (0.48) METFLT3AXLKDR
SCHEMBL20525650 0.91 MET (0.49) METFLT3AXLKDR
SCHEMBL20525799 0.91 MET (0.46) METFLT3AXLKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 EP claimed